Rituximab for intraocular lymphoma.
Itty
Sujit
S
Pulido
Jose S
JS
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D005134:Eye Neoplasms / Q000188:drug therapy*; D006801:Humans; D016393:Lymphoma, B-Cell / Q000188:drug therapy*; D019574:Optic Nerve Neoplasms / Q000188:drug therapy*; D019572:Retinal Neoplasms / Q000188:drug therapy*; D000069283:Rituximab; D014822:Vitreous Body
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab